University of Rhode Island

DigitalCommons@URI
Open Access Master's Theses
2013

EFFECTS OF POSITION AND ORIENTATION ON PAX6 UPSTREAM
ENHANCERS IN CIONA INTESTINALIS
Thomas Andrew Bregnard
University of Rhode Island, thomas_bregnard@my.uri.edu

Follow this and additional works at: https://digitalcommons.uri.edu/theses

Recommended Citation
Bregnard, Thomas Andrew, "EFFECTS OF POSITION AND ORIENTATION ON PAX6 UPSTREAM
ENHANCERS IN CIONA INTESTINALIS" (2013). Open Access Master's Theses. Paper 166.
https://digitalcommons.uri.edu/theses/166

This Thesis is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion
in Open Access Master's Theses by an authorized administrator of DigitalCommons@URI. For more information,
please contact digitalcommons@etal.uri.edu.

EFFECTS OF POSITION AND ORIENTATION ON PAX6 UPSTREAM
ENHANCERS IN CIONA INTESTINALIS
BY
THOMAS ANDREW BREGNARD

A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF
MASTER OF SCIENCE
IN
CELL AND MOLECULAR BIOLOGY

UNIVERSITY OF RHODE ISLAND
2013

MASTER OF SCIENCE THESIS
OF
THOMAS ANDREW BREGNARD

APPROVED:
Thesis committee:
Major Professor

Steven Irvine
Niall Howlett
Becky Sartini
Nasser H. Zawia
DEAN OF THE GRADUATE SCHOOL

UNIVERSITY OF RHODE ISLAND
2013

ABSTRACT
The classical definition of genetic cis-regulatory modules such as
enhancers identifies these elements as insensitive to changes in position and
orientation relative to the transcription start site (TSS). While this theory is well
supported, some recent studies have uncovered examples of constraint in the
position or orientation of particular enhancers. This study examines the position
and orientation sensitivity of two upstream enhancer elements found in the gene
Pax6, which regulates development of the eyes and central nervous system in
vertebrates. Late embryonic stages of the organism used in this study, Ciona
intestinalis, show expression of Pax6 in the nerve cord and sensory vesicle.
For this investigation Pax6 constructs were created in which the enhancers
were repositioned or inverted relative to the TSS. These constructs were
electroporated into embryos of C. intestinalis, and expression of the Pax6-GFP
fusion gene was measured both by total fluorescence and by number of positive
embryos. Alteration of either position or orientation of these enhancers was found
to cause a strong decrease in measured Pax6 expression. These results support the
conclusion that the upstream enhancers must be in the proper location and
arrangement to be fully functional, a finding that is consistent with the results of
many other studies of cis-regulatory elements.
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INTRODUCTION
Enhancers and other cis-regulatory elements
The expression of genetic information as traits relies on a group of DNA
elements collectively referred to as cis-regulatory elements. These DNA elements
are located on the same strand of DNA as the genes they regulate; the function of
these elements is to control the degree to which their target genes are expressed as
well as when during development and in what cells these genes are expressed.
One type of cis-regulatory element is the enhancer, so named because it increases
the expression of the target gene (reviewed in Atchison, 1988). An enhancer is
typically found upstream from the gene it regulates, although some enhancers are
found downstream of their target genes or within introns of the target genes.
Regulation of gene expression is accomplished through transcription factors
(TFs), which are proteins that bind particular DNA elements in order to promote
or suppress gene expression. Specific TFs bound to the enhancer element will
form a complex with general TFs bound to the basal promoter, a DNA element
that marks the start site for the process of transcription (Ptashne, 1986; Ptashne,
1988). This interaction of specific and general TFs will influence the extent to
which the target gene is expressed.
In the 1980s a number of studies of enhancers and other cis-regulatory
elements established the theory that these elements are flexible in their position
and orientation relative to the transcription start site (TSS). These studies
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examined enhancers from diverse systems, such as Moloney murine sarcoma
virus (Laimins et al., 1984), hepatitis B virus (Shaul et al., 1985), yeast (Elion and
Warner, 1986), and the mouse (Jaynes et al., 1988). For each study the enhancers
for particular genes were repositioned relative to the TSS, reversed in their
directional orientation relative to the TSS, or both; the amount of expression of
these genes was then measured and compared to the expression level using the
default enhancer setup. These studies concluded that the enhancers still
functioned in an altered position or orientation.
The results of studies such as these established the idea that enhancer
function is unaffected by changes to the position and orientation of these
elements, an idea that eventually became a criterion for establishing a DNA
element as an enhancer. By the end of the same decade a mechanism had been
discovered that explained the basis for this flexibility. In this model (Ptashne,
1986; Ptashne, 1988) the non-coding DNA between an enhancer and the basal
promoter forms a loop that brings these two elements into close proximity to one
another. TFs bound to each of these elements are then in the correct position to
interact and stimulate transcription. Since the size of the loop does not matter, a
change in enhancer position would affect the size of the loop formed but would
preserve crucial TF interactions. Similarly, a change in enhancer orientation
would cause a slightly different loop structure to form but would not affect the
interactions of TFs. Because the necessary TF interactions are preserved in this
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model, the level of transcription is not affected by alterations to the enhancer
position or orientation.
In many of these same early studies, however, the altered position and
orientation of the enhancers did appear to reduce the level of expression of these
genes. Expression from the murine muscle creatine kinase promoter dropped to
approximately 20% when the upstream enhancer was either moved to a position
downstream of the reporter gene or inverted (Jaynes et al., 1988). Similarly, an
enhancer from the long terminal repeat of Moloney murine sarcoma virus was
found to be only 30 to 40% active when moved downstream of the reporter gene
(Laimins et al., 1984). An enhancer from hepatitis B virus (HBV) gave values in
the range of 50 to 300 in the forward orientation as measured by a
chloramphenicol acetyltransferase (CAT) assay, while expression using the
inverted enhancer ranged from 25 to 50 (Shaul et al., 1985). Such results indicate
that while an enhancer may still be able to function if its position or orientation is
affected, such alterations to the enhancer do reduce the level of expression to
some extent. The reduction in enhancer activity found in these studies was
generally overlooked at the time of these investigations.
In more recent years there have also been a few studies that have
uncovered enhancers that do not behave in the traditional way. One such study
(Kim et al., 2008) examined two cis-regulatory elements in mice. One, the CSE2
element, is an enhancer that promotes expression of the TF-encoding gene Peg3.
The other, the CSE1 element, is a silencer for two co-regulated genes, Peg3 and
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Usp29. Silencers differ from enhancers in that silencers suppress expression of
their target genes. Silencers also show the same position and orientation flexibility
as enhancers. This study, however, revealed a near complete loss of regulation of
the target gene Peg3 when either element was inverted. Inversion of the enhancer
CSE2 caused a drop in expression from 1.7 fold to 1.1 fold. These numbers are in
reference to the 1.0 fold expression observed when CSE2 was deleted from the
DNA. In the case of the silencer CSE1, inversion caused expression to increase to
2.5 fold. By comparison, deletion of CSE1 gave 2.7 fold expression of Peg3. The
effect of CSE1 orientation on silencing of Usp29 was not examined in this study.
Another study in the fruit fly Drosophila melanogaster (Small et al.,
1993) examined the expression of the even-skipped (eve) gene, which controls
patterns of striping. The eve gene is controlled by several upstream enhancers.
Correct expression of this gene was found to be dependent on a minimum length
of sequence separating two of the upstream enhancers; various abnormalities
result when they are placed too close together. It is important to point out that in
the eve gene investigation the enhancers are constrained by their positions to each
other rather than to the TSS.
In addition to functional studies, several sequence conservation studies
have identified genes in which the position and orientation of enhancers are
evolutionarily conserved. Sequence conservation typically indicates that a region
of DNA has some important function, such as a gene or a cis-regulatory element.
Similarly, if the orientation of an enhancer or its distance from the TSS is
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conserved, this may indicate that the observed position or orientation is necessary
for correct gene expression. One recent sequence conservation study (Goode et
al., 2005) compared human chromosomal region 7q36 to the genome of the
pufferfish Fugu rubripes and identified a number of conserved non-coding
sequence elements in which the position and orientation were conserved. In a
subsequent functional assay, most of these conserved elements were found to
function as enhancers.
The developmental gene Pax6
The gene Pax6 plays an important role in development of the eyes and
nervous system in both vertebrates and invertebrates (reviewed in Simpson and
Price, 2002, and in Thompson and Ziman, 2011). The Pax6 protein encoded by
this gene functions as a transcription factor. The Pax family TFs contain an Nterminal paired domain used in binding target genes and a C-terminal
transactivation domain that mediates protein-protein interactions; Pax6 also
includes a DNA-binding homeodomain (Thompson and Ziman, 2011). The
functions of Pax6 are highly diverse, including roles in patterning of the central
nervous system (CNS), control of cell migration, expression of cell surface
adhesion molecules, and promoting both proliferation and differentiation of
neurons in the eyes and CNS at different stages of development (Simpson and
Price, 2002; Thompson and Ziman, 2011). The functions of Pax6 differ between
cell types, due in part to at least two isoforms of the Pax6 protein with different
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specificities for target genes (Simpson and Price, 2002; Thompson and Ziman,
2011).
Mutations in PAX6 are associated with a variety of phenotypic
abnormalities in humans. One of these is the autosomal dominant condition
aniridia, reviewed in (Lee et al., 2008). Aniridia is caused by mutations in PAX6
that cause premature termination of translation; these are commonly nonsense
mutations or frameshift insertions or deletions. The reduced level of functional
PAX6 protein results in improper development and maintenance of the cornea,
lens, optic nerve, and other components of the eye. This condition can include
aniridia-associated keratopathy, a corneal disorder that results in dry or red eyes,
photophobia, increased watering of the eyes, and vision loss. Aniridia can also
lead to glaucoma due to improper drainage. PAX6 mutations have been implicated
in other eye disorders such as keratitis, certain cataracts, and Peter’s anomaly
(Simpson and Price, 2002; Thompson and Ziman, 2011). Animal models with
Pax6 mutations show various eye and brain disorders such as an aniridia-like
small eye, also known as microphthalmia (Simpson and Price, 2002; Thompson
and Ziman, 2011). Abnormal phenotypes may result from loss of expression or
overexpression of Pax6, indicating that proper Pax6 function is concentrationdependent (Simpson and Price, 2002; Thompson and Ziman, 2011).
Pax6 was chosen as the gene of interest in this project for several reasons.
Since the function of Pax6 is widespread and very sensitive to concentration of
the protein, any change in Pax6 expression as a result of an altered cis-regulatory
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module could cause a harmful phenotypic change. There have also been many
studies of cis-regulation of Pax6 and its homologs in various systems such as the
mouse (Xu et al., 2002; Kleinjan et al., 2004; Kleinjan et al., 2006; Kammandel et
al., 1999), fruit fly (Adachi et al., 2003; Hauck et al., 1999), and others (Griffin et
al., 2002; Kammandel et al., 1999; Plaza et al., 1999). These studies allow
comparisons of effects on cis-regulation to be made across diverse species. In
addition, the Irvine lab has previously identified the major cis-regulatory regions
that appear to be necessary for Pax6 expression in Ciona intestinalis (Irvine et al.,
2008).
The model organism Ciona intestinalis
The organism used in this study is the sea squirt Ciona intestinalis,
discussed in (Satoh, 1994). Sea squirts, or ascidians, are ubiquitous in marine
environments worldwide (Satoh, 1994). The adults are sessile filter feeders with a
tube- or barrel-shaped body. The body has two tubular openings: an oral siphon
that takes in food and oxygenated water, and an atrial siphon that expels waste
and deoxygenated water (Satoh, 1994). Ciona is a hermaphroditic organism but is
self-sterile; fertilization requires gametes from different individuals. The embryos
of C. intestinalis include tailbud stages that resemble tadpoles; these embryos are
the focus of this study.
C. intestinalis is an ideal choice for studying expression of transgenes for
several reasons (reviewed in Satoh et al., 2003). First, a simple electroporation
method has been developed to introduce a single transgene into large numbers of
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fertilized C. intestinalis eggs (Corbo et al., 1997). In addition, a second draft of
the C. intestinalis genome has been published (Dehal et al., 2002). Comparison of
sequences between C. intestinalis and the closely related species C. savignyi has
proven to be an effective tool for locating conserved non-coding DNA elements
such as enhancers (Johnson et al., 2004; Irvine et al., 2008; see Figure 1).
Furthermore, embryos of C. intestinalis are transparent and have a relatively small
number of cells; the cells are large and easily distinguished under a microscope.
The developmental fates of all cells in the early embryonic stages of this organism
have been well documented. This means that expression patterns of transgenes
introduced by electroporation can be directly observed and measured at any of the
various embryonic stages, and that these results can be collected in a cell- or
tissue-specific manner.
Hypothesis
Since many previously studied enhancers show some sensitivity to
changes in position or orientation, it is worth investigating whether this
phenomenon is common among cis-regulatory DNA elements. This investigation
focuses on two enhancer elements, named UB and UA, located approximately 1.8
kb upstream of the TSS of the C. intestinalis Pax6 (CiPax6) gene; Figure 1 shows
the locations of cis-regulatory elements identified in CiPax6. These two
enhancers work synergistically to form a single cis-regulatory module. Here I
present evidence that the UB-UA enhancer cassette loses much of its regulatory
function when inverted or moved closer to the TSS. These results are similar to
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Figure 1. Conserved functional regions in CiPax6. A VISTA plot of conserved
sequence regions between Ciona intestinalis and Ciona savignyi is shown above a
diagram of major functional regions identified in the CiPax6 gene. CiPax6
contains four regions with experimentally confirmed cis-regulatory functions,
shown in this diagram as pink ovals. The upstream UB and UA enhancer elements
promote expression of Pax6 in the nerve cord and in the sensory vesicle of the
brain. A third enhancer within the first intron promotes expression in the
photoreceptor cells and the nerve cord. The element within the fourth intron acts
as a silencer. Image taken from (Irvine et al., 2008).
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observations from other enhancer elements, suggesting that this phenomenon of
position and orientation sensitivity is more common in enhancers than previously
recognized.
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METHODS
Production of test vectors
Vector Lig 1 was produced from the experimental vector CiP6-2.5UI1
used and discussed in Irvine et al., 2008. CiP6-2.5UI1 contains a portion of the
CiPax6 gene beginning 2.5 kb upstream of the TSS and ending within the first
exon. This fragment includes the upstream UB and UA enhancer elements
followed by approximately 1.8 kb of non-coding DNA separating the enhancers
from the TSS. The intron 1 enhancer, which promotes expression in the nerve
cord and photoreceptor cells (Irvine et al., 2008), is also included in this vector.
CiP6-2.5UI1 also contains a nuclear localization signal (NLS), lacZ reporter gene
sequence, and a SV40 polyadenylation signal. Lig 1 was created by replacing the
lacZ reporter sequence with GFP cDNA.
Lig 2 was intended to be a vector with the upstream enhancer cassette
inverted in orientation. This vector was not successfully produced, however;
therefore the discussion of this vector is skipped in this thesis.
Lig 3 was produced by digesting vector 1 with ClaI and NruI to remove a
1.15-kb piece of DNA from between the upstream enhancers and TSS. The piece
of DNA removed from this clone was a piece of non-coding, non-conserved DNA
that was believed to exclude any TF binding sites from the enhancers or the basal
promoter. The ClaI overhang was blunted with T4 DNA polymerase, and the
vector was ligated.
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GW 1, GW 2, and GW 3 were produced using the Gateway recombination
system (Invitrogen). These vectors were designed to be similar to Lig 1, Lig 2,
and Lig 3, respectively; however, the vectors produced through the recombination
method include attB recombination sites at both ends of the enhancer cassette.
The production of comparable vectors by two different methods was used to
check that any effects observed was not an artifact of the way in which the
plasmids were made. Prior to the production of these vectors, the intermediate
vector Aux 1 was produced. Aux 1 was prepared by digesting Lig 1 with AscI and
HindIII, which removed a 19 base pair fragment immediately upstream of the
enhancers. A Gateway recombination cassette was ligated into this site to produce
Aux 1.
Next the entire vector except the enhancer region was amplified by PCR
using primers that bind outside the enhancer region. This PCR product was then
phosphorylated with T4 polynucleotide kinase and ligated. The product of this
reaction, Aux 2, was used as the destination vector in the generation of vectors
GW 1 and GW 2.
To produce GW 1, a copy of the enhancer cassette was first amplified with
attB recombination sites at both ends. This product was used in a BP reaction with
the vector pDONR221 (Invitrogen) to produce an entry vector with the enhancer
cassette in the forward orientation. This entry vector was then used in a LR
reaction with Aux 2, resulting in production of GW 1. GW 2 was produced
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through a similar strategy, but the entry vector contained the enhancer cassette in
the flipped orientation.
The destination vector for production of GW 3 was generated by digesting
Aux 1 with AscI and NruI. This reaction removed a segment that was 1922 bases
in length on the coding strand. The 5’ overhang left by AscI was filled using T4
DNA polymerase, and the vector was ligated to produce Aux 3. This new
destination vector was used in a LR reaction with the previously mentioned entry
vector containing the enhancers in the forward orientation, resulting in the
production of vector GW 3.
The upstream promoter regions of all plasmids tested in this investigation
are diagrammed in Figure 2.
Collection and quantification of DNA
Plasmids were transformed into chemically competent TOP10 E. coli.
DNA was harvested from overnight cultures by midiprep. For quantification,
samples of known volumes of each plasmid were digested with XhoI, which cuts
at a single site upstream of the enhancers. Concentrations of the linear vectors
were determined on agarose gels using the GeneTools software from SynGene.
Fertilization and transformation of embryos
Adult animals were obtained locally from the Point Judith Marina at Snug
Harbor, Rhode Island, or purchased from M-Rep, Carlsbad, California. Gametes
were collected from adult animals by dissection, and fertilization was performed
in vitro.
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Figure 2. Maps of experimental and intermediate vectors. Relevant sequence
elements are shown, beginning with enhancers and ending with GFP transgene.
Distances represented are not drawn to scale. Arrows above enhancers represent
orientation; right is forward and left is reversed. (A) Lig 1 is the positive control
for ligation-generated vectors. (B) Lig 3 contains the upstream enhancers at a
distance of 0.6 kb from the TSS. (C) GW 1 is the positive control for
recombination-generated vectors. (D) GW 2 contains the enhancer cassette in the
reversed orientation. (E) GW 3 contains the enhancer cassette at a distance of 0.5
kb from the TSS. (F-H) The Aux vectors were intermediates used to produce the
tested vectors. They are described in the Methods section and are therefore
included in this figure.
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Dechorionation and electroporation were performed 10 minutes after the
completion of fertilization. The protocol used was a modified version of a
previous protocol used by the Irvine lab (Vierra and Irvine, 2012). Briefly,
fertilized eggs were dechorionated using 0.4 mg/ml Pronase E in 1% sodium
thioglycolate in 3.3% sodium chloride pH 10.1 for 3 to 5 minutes at 18°C.
Dechorionation was quenched by transferring eggs to 1 mM glycine in phosphate
buffered saline (PBS). For each electroporation, 250 µl of eggs in filtered
seawater (FSW) were added to a solution containing 50 µg of DNA in 100 µl of
water and 350 µl of 1 M mannitol. Electroporation was performed using a BTX
ECM 830 square wave electroporator. The settings for all electroporations were
32 V, 100 ms. Actual voltage ranged from 20 V to 30 V, with nearly all samples
electroporated at 27 V or 30 V; all electroporation times were 100 ms. Following
electroporation, embryos were raised in gelatin-coated dishes of FSW containing
approximately 15 U/ml penicillin and 15 µg/ml streptomycin. The rearing
temperature used was 14°C.
Embryo fixation
All embryos were fixed for analysis at late tailbud stage 1 or 2, around 18
to 22 hours post fertilization when raised at 14°C. Embryos were fixed for 10 min
in 2% paraformaldehyde in the dark. After removal of fixative, embryos were
incubated in 100 mM glycine in PBS for 30 min to reduce autofluorescence of
muscle cells. Glycine was then washed out three times with either PBS or PTw
(PBS + Tween 20), and embryos were left in PTw until the time of analysis.
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Photography of embryos
In preparation for analysis, embryos were incubated in PBS for 30 min;
this PBS served as the mounting medium for microscopy. Slides were prepared by
placing two layers of Scotch tape on each side of the slide, to the left and right of
where the embryos would be placed. The two layers of tape served the purpose of
preventing the embryos from being crushed when a cover slip was placed over
them. After the tape was added, the surfaces of the slides and tape were greased
with Rain-X except in the middles, where the embryos were to be placed. The
slides were then cleaned with Windex. Embryos were mounted in a small drop of
PBS between the taped areas of each slide. A cover slip was then laid over the
embryos such that the edges of the cover slip were held up by the tape.
Embryos were viewed by epifluorescence illumination microscopy. Each
embryo was photographed under a GFP filter using a SPOT Flex digital camera
(Diagnostic Instruments). The image setting for all embryos were as follows:
fluorescence as the image type, manual exposure, and 251.6 ms as the exposure
time. All other settings were left as default. Embryos were photographed within
three days after fixation.
Data analysis
All embryos were visually scored for expression or lack of expression of
the reporter gene GFP using the following definitions. A positive score means
that the embryo showed fluorescence in the sensory vesicle above the normal
level of autofluorescence, fluorescent nuclei along the nerve cord, or fluorescence
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in both locations. A negative score means that no increase in fluorescence was
detected in the nerve cord or sensory vesicle. A score of ambiguous means that
there appeared to be a slight increase in fluorescence observed in the sensory
vesicle or increased fluorescence in the nerve cord without confirmed nuclear
localization, but that the observed fluorescence was not definitely attributable to
GFP.
Embryos were also measured for green fluorescence using the program
ImageJ. For this analysis embryo photographs were first converted to grayscale in
Adobe Photoshop. These images were too dim to be visible, so the white input
level was reduced from 255 to 30 for each photograph using Photoshop. The
adjusted images were then opened in ImageJ. For each photograph four
measurements were performed. The first measurement was of the entire embryo
or the trunk portion of the embryo, as specified in the results of each analysis. The
next three measurements were square sections of the background fluorescence.
All measurements included the values of area, mean gray value, and integrated
density. Integrated density is the sum of the gray values of all pixels in the
measured area; mean gray value is the average intensity per pixel in the measured
area.
Whole embryo measurements were corrected for autofluorescence using a
set of negative control embryos photographed the same number of days after
fixation as each experimental or positive control embryo. The negative control for
each trunk measurement was a section of autofluorescence from the trunk of the
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same photograph. The mean gray value for the negative control was subtracted
from the mean gray value of the embryo being measured to give the corrected
density. These corrected density values were averaged for all embryos in each
trial. Corrected mean density values are presented as both raw values and
normalized values. Vector Lig 3 was normalized against Lig 1, while vectors GW
2 and GW 3 were normalized against GW 1; normalized values are given as
percentages of expression relative to Lig 1 or GW 1 from the same set of trials.
Statistical analysis was performed on all raw data using Student’s t-test.
For the statistical analysis each experimental trial was compared to the positive
control from the same trial set; the Lig 1 and GW 1 trials were also compared. All
t-tests were 2-tailed and assumed unequal variance. The assumption of unequal
variance was made because there was variability in the observed GFP
fluorescence and autofluorescence between trials. The F-test for each statistical
comparison was also performed to examine the variance. F-values were calculated
offline, then p-values were calculated using the Free p-Value Calculator for an FTest at (http://www.danielsoper.com/statcalc3/calc.aspx?id=7). Calculated pvalues for the F-test ranged from 0.019 to 0.495.
For each comparison using the t-test, the p value was calculated using the
online T-Test Statistics Calculator at (http://studentsttest.com/). Results of the ttest are presented on each graph. The definitions of these statistical results are as
follows. A dash (-) represents a p value of 0.05 or greater. One star (*) represents
a p value between 0.05 and 0.005. Two stars (**) represents a p value between
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0.005 and 0.0005. Three stars (***) represents a p value less than 0.0005. For this
investigation a p-value of less than 0.05 is considered statistically different.
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RESULTS
Constructs in which the position or orientation of upstream enhancers
has been altered show visibly reduced expression of GFP in C. intestinalis
embryos as compared to the positive control constructs. Table 1 shows the
number and percentage of embryos from each trial that were scored as positive,
ambiguous, and negative. Lig 1 and GW 1 are positive controls for the ligation
and recombination methods of vector production, respectively. In two separate
trials 100% of embryos containing Lig 1 were positive; GW 1 yielded 93%
positive and 7% ambiguous embryos in one trial and 100% positive embryos in
another. All positive control embryos showed strong GFP expression in the
sensory vesicle, and some showed nerve cord expression from either positive
control; embryos containing Lig 1, but not GW 1, also showed non-nuclear
expression in muscle cells in the tail. The expression in the tail muscle cells is
assumed to be ectopic, since all plasmids used in this investigation encode GFP
with a nuclear localization signal. Figure 3 contains representative photographs of
embryos electroporated with each construct. The two ambiguous embryos
containing GW 1 show slightly higher fluorescence in the sensory vesicle than the
no-DNA controls, and although they cannot be conclusively scored as positive,
they are predicted to be expressing GFP at a low level. These high percentages of
positive embryos confirm that both of the positive control vectors drive
expression of GFP.
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Construct

n

# (+)

% (+)

#A

%A

# (-)

% (-)

Lig 1-1

11

11

100

0

0

0

0

Lig 1-2

3

3

100

0

0

0

0

Lig 3-1

23

7

30

6

26

10

43

Lig 3-2

5

1

20

1

20

3

60

GW 1-1

30

28

93

2

7

0

0

GW 1-2

26

26

100

0

0

0

0

GW 2-1

26

0

0

3

12

23

88

GW 2-2

9

2

22

4

44

3

33

GW 3-2

10

0

0

5

50

5

50

(-) C-2

12

0

0

0

0

12

100

Table 1. Quantification of embryos expressing GFP. All embryos were scored
as positive [(+)], negative [(-)], or ambiguous (A) for GFP expression. Scores for
each trial are given as number (#) and percentage (%) of embryos in each
category; n refers to the total number of embryos in each trial. Trials are labeled
with the name of the plasmid used, followed by a hyphen, then the number of the
trial set; this trial naming system is also used in certain places in the text. All trials
with the same trial set number were performed simultaneously. (-) C-2 is the noDNA negative control used in trial set 2.
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(A)

(B)

(C)

(D)

(E)

(F)

(G)

(H)

Figure 3. Representative photographs from trials with each plasmid. All
images have been scaled to 25% of the original height and width in Photoshop.
(A-C) These photographs have been enhanced by decreasing maximum RGB
input levels from 255 to 20 to reproduce the appearance under the microscope.
Areas of GFP expression are indicated by arrows and the following labels: SV,
sensory vesicle; NC, nerve cord; E, ectopic expression. (A) Lig 1 embryo; nerve
cord expression is occurring but is not visible. (B) GW 1 embryo showing
fluorescent nuclei in the nerve cord. (C) Negative control embryo containing no
DNA; control for autofluorescence.
(D-H) These images have been converted to grayscale, and the white input level
has been reduced from 255 to 15. (D) Lig 1 embryo. (E) Lig 3 embryo. (F) GW 1
embryo. (G) GW 2 embryo. (H) GW 3 embryo.
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Construct GW 2 contains the upstream enhancers in the flipped
orientation. The results of two trials with this vector were somewhat mixed. The
breakdown of embryos from one trial with GW 2 was 12% ambiguous and 88%
negative, but a second trial gave 22% positive, 44% ambiguous, and 33%
negative embryos. Most GW 2-containing embryos scored as ambiguous showed
weak non-nuclear fluorescence in the nerve cord, which usually shows no
autofluorescence. However, some control embryos containing no transgene
showed similar fluorescence. These results for GW 2 indicate that the flipped
enhancers are less effective at promoting GFP expression than the same
enhancers in the default orientation. A lack of visible expression in most embryos,
however, does not rule out the possibility of low levels of GFP that are invisible
to the unaided eye.
Constructs Lig 3 and GW 3 have the upstream enhancers moved closer to
the TSS. Lig 3 yielded 30% positive and 26% ambiguous embryos in one trial; a
second trial yielded 20% positive and 20% ambiguous embryos. Most of the
positive embryos were weakly positive; these data suggest that Lig 3 promotes a
low level of GFP expression that is visible in some embryos but not in others. The
data for GW 3 do not match those of Lig 3. One trial was performed with GW 3,
in which 50% of embryos were scored as ambiguous and 50% were scored as
negative. The ambiguous embryos showed non-nuclear fluorescence in the nerve
cord only, which makes them more likely to be negative. GW 3 therefore does not
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promote expression of GFP to a visible level using the methodology of this
investigation.
There is a modest difference in measured GFP expression from GW 1
versus from Lig 1. Embryos were analyzed for fluorescence using ImageJ, as
described in the Methods section of this thesis. For trial set 2 the negative control
was a set of embryos that were fertilized, dechorionated, and fixed alongside these
trials, but were not electroporated and did not receive any foreign DNA. A noDNA control was not available for trial set 1, so Lig 2-1 was used as the negative
control for this set of trials. This decision was made because Lig 2-1 gave the
lowest corrected mean density value and because nearly all embryos in this trial
were scored as negative for visible GFP expression.
Figure 4 shows corrected mean density values for all whole embryo trials
performed. In trial set 1, Lig 1 gave a mean value of 899 ± 526 while GW 1 gave
a mean value of 647 ± 632. The values from trial set 2 were 1394 ± 126 for Lig 1
and 998 ± 614 for GW 1. This increased fluorescence in trial set 2 relative to trial
set 1 was, in general, consistent among individual positive control embryos.
Normalized values and statistical analysis for the positive controls are shown in
Figure 5. In both trial sets the normalized mean value of GW 1 is approximately
72% that of Lig 1 in spite of the differences in raw mean values between trial sets.
This difference was determined to be statistically significant for trial set 2 (p =
0.012) but not for trial set 1 (p = 0.213).
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Figure 4. Raw fluorescence values from whole embryo analysis. All constructs
except GW 3 were tested in two separate trials; values from trial set 1 are given in
blue, and values from trial set 2 are given in red. Results of t-tests follow the same
color coding. Trial GW 2-2 gave a negative value but is represented as zero in this
graph. Error bars represent the standard deviation of each trial.
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Figure 5. Normalized fluorescence of controls, whole embryo analysis.
Corrected mean density values of the positive control trials from the whole
embryo analysis were normalized against Lig 1. For each construct values from
trial set 1 are given in blue, and values from trial set 2 are given in red. Results of
t-tests follow the same color coding. The statistical results shown in this graph
were taken from the raw data, not the normalized values.
Error bars represent a combined standard deviation for the trial and the control
against which it was normalized. For the combined standard deviation the
standard deviations of the individual trials were treated as random error and
propagated as follows. Standard deviations were first converted to percentages of
the trial mean. These percent error values were squared, and the two squares were
added. The square root of this sum was then taken to get the relative standard
deviation as a percentage of the normalized mean. This percentage was then
multiplied by the normalized mean to give the combined standard deviation.
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All experimental constructs yield lower levels of GFP expression than
positive control constructs as measured by ImageJ. Figure 4 shows that all
experimental constructs show lower corrected mean density values than the two
positive controls. Normalized values for the experimental trials are given in
Figure 6. The two trials with GW 2 gave mixed results. GW 2-1 gave a mean
value of 460 ± 632, which is approximately 71% of the mean value for GW 1-1.
The mean value of GW 2-2 was measured as -546 ± 442. This mean value was
displayed as zero in Figure 4; the standard deviation was not changed. The t-test
identified the difference between GW 2 and GW 1 as highly significant for trial
set 2 (p = 1.6 × 10-7) but not significant for trial set 1 (p = 0.274). These GW 2
measurements do not correlate with the visual observations recorded in Table 1;
no positive embryos were seen in GW 2-1, but GW 2-2 gave 22% weakly positive
embryos. This difference is most likely due to lower average autofluorescence in
GW 2-2. Autofluorescence varied between trials and between embryos within
each trial. Most of this autofluorescence was naturally occurring green
fluorescence in muscle cells in the tails of the embryos, although the trunks also
showed some autofluorescence. In trials where there was very little or no GFP
expression, some embryos gave negative corrected density values due to low
autofluorescence. All nine embryos in GW 2-2 gave negative values, producing a
negative mean value for the trial.
Removal of most of the non-coding sequence from between the enhancers
and TSS also caused a loss of measured total fluorescence, although this loss was
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Figure 6. Normalized fluorescence of experimental embryos, whole embryo
analysis. Corrected mean density values from Figure 4 were normalized against
the corresponding positive control as described in the Methods section. Values are
shown as a percentage of Lig 1 or GW 1 from the same trial set. Values from trial
set 1 are given in blue, and values from trial set 2 are given in red. Results of ttests follow the same color coding. The statistical results shown in this graph were
taken from the raw data, not the normalized values.
Trial GW 2-2 gave a negative value but is represented here as a zero on the chart.
Error bars represent a combined standard deviation for the trial and the control
against which it was normalized. See figure 5 for an explanation of how the
combined standard deviations were calculated.
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less dramatic than that caused by inversion of the enhancer cassette. Two trials
with Lig 3 yielded raw mean values of 370 ± 389 and 486 ± 784. These values are
41% of Lig 1-1 and 35% of Lig 1-2, respectively. This loss of expression is
statistically significant for the first trial set (p = 0.010) but not the second trial set
(p = 0.060). While these trials suggest a substantial decrease in GFP expression
from Lig 3, the visual observations of these embryos suggest that the actual
decrease in expression is greater. Trial GW 3-2 gave a raw score of 332 ± 650,
which is 33% the level of expression from GW 1-2. This result was statistically
significant (p = 0.013). The relatively high score from this trial appears to be due
mainly to autofluorescence, since no positive embryos were observed in this trial.
All trials showed rather high standard deviations, as shown in Figure 4. In
general, embryos within each trial showed substantial differences in corrected
mean density, although these values were more or less evenly distributed around
the average. Two factors that contributed to this high variability in the data were
autofluorescence and background fluorescence, both of which differed from
embryo to embryo. Autofluorescence is mainly due to naturally occurring green
fluorescence in muscle cells. Background fluorescence occurs in the mounting
medium and can be due to certain fluorescent particles or compounds present
around the embryo. The combined mean density of autofluorescence and
background fluorescence was much larger than the mean density from the true
fluorescent signal in all trials. Small differences in either or both of these sources
of fluorescence could therefore cause large variations in the corrected mean
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density values. Another source of error that affected all trials was the positioning
of embryos. Not all embryos were positioned correctly for a single photograph to
capture the whole embryo in focus. Parts of the embryo that were out of focus
became blurry and gave a diffuse fluorescent signal, which resulted in a lowerthan-expected fluorescence measurement. A final source of error that may have
affected all embryos except the negative controls was mosaic expression of the
transgene. Following electroporation, depending on how the transgenic plasmid is
distributed in the egg, it will be partitioned unevenly between cells as the embryo
develops. This will cause variation in how much DNA is present in regions that
normally express Pax6.
Measurements of fluorescence in only the trunk portions of embryos
give a clearer confirmation of loss of expression in all experimental embryos.
Most of the GFP fluorescence in these trials is found in the sensory vesicle of the
brain (Irvine et al., 2008; Figure 3), while the strongest autofluorescence is seen
in the tail (Figure 3C). In order to reduce the impact of autofluorescence on the
data collected, the photographs were also analyzed by measuring only the
fluorescence in the trunk portions of the embryos. Measurements were taken in
the same manner as in the whole embryo analysis except that a different method
was used to correct for autofluorescence. In this analysis each embryo
measurement was individually corrected for autofluorescence by measuring a
portion of the trunk excluding the brain and using this mean density value as the
control for autofluorescence. The corrected mean density scores from the trunk
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based analysis are given in Figure 7. Normalized scores from this analysis are
given for the positive controls in Figure 8 and for the experimental trials in Figure
9.
Using this method the corrected mean density values for Lig 1 were 1293
± 520 and 2044 ± 474 in trial sets 1 and 2, respectively. The higher values seen in
the trunk based analysis versus the whole embryo analysis are due to a
combination of more concentrated GFP signal in the trunk and lower
autofluorescence. The two trials with the control GW 1 gave corrected mean
values of 837 ± 385 for trial 1and 1229 ± 393 for trial 2. These values are 65%
and 60% of the corresponding Lig 1 values, respectively. The difference in
expression between the controls was statistically significant for trial 1 (p = 0.019)
but not for trial 2 (p = 0.086).
As in the whole embryo analysis, the trunk-based analysis revealed lower
fluorescence in all experimental constructs than in the two positive controls. GW
2 gave values of 104 ± 521 in trial set 1 and 657 ± 190 in trial set 2. These values
are 12% and 53% of GW 1, respectively. This loss of expression is statistically
highly significant for both trial set 1 (p = 4.2 × 10-7) and trial set 2 (p = 3.3 × 106

). These results do not match up with the whole embryo results, for which trial 1

was measured at 71% of the control and trial 2 gave a negative value. The visual
observations of positive GW 2 embryos agree with the results of the trunk-based
analysis, not the whole embryo analysis. Lig 3 gave values of 517 ± 312 in trial 1
and 829 ± 272 in trial 2. The normalized values for this construct are 40% and
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Figure 7. Raw fluorescence values from trunk based analysis. Raw corrected
mean density values for all trials performed, determined for trunk portions of
embryos. For each construct values from trial set 1 are given in blue, and values
from trial set 2 are given in red. Results of t-tests follow the same color coding.
The negative control from trial set 2 was included in the trunk based analysis and
is labeled (-) C. Statistical analysis is not shown for the negative control in order
to maintain readability. Error bars represent the standard deviation of each trial.
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Figure 8. Normalized fluorescence of controls, trunk based analysis.
Corrected mean density values of both positive controls from the trunk-based
analysis were normalized against Lig 1. Values from trial set 1 are given in blue,
and values from trial set 2 are given in red. Results of t-tests follow the same
color coding. The statistical results shown in this graph were taken from the raw
data, not the normalized values.
Error bars represent a combined standard deviation for the trial and the control
against which it was normalized. See figure 5 for an explanation of how the
combined standard deviations were calculated.
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Figure 9. Normalized fluorescence of experimental embryos, trunk based
analysis. Corrected mean density values for trunk based analysis were normalized
against the corresponding positive control as described in the Methods section.
Values are shown as a percentage of Lig 1 or GW 1 from the same trial set.
Values from trial set 1 are given in blue, and values from trial set 2 are given in
red. Results of t-tests follow the same color coding. The statistical results shown
in this graph were taken from the raw data, not the normalized values.
The negative control from trial set 2 is included and is labeled as (-) C. Statistical
analysis is not shown for the negative control in order to maintain readability.
Error bars represent a combined standard deviation for the trial and the control
against which it was normalized. See figure 5 for an explanation of how the
combined standard deviations were calculated.
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41%, respectively. This loss of expression is highly significant for trial set 1 (p =
4.8 × 10-4) and significant for trial set 2 (p = 0.030). The trial with GW 3 gave a
value of 515 ± 296, which is 42% of GW 1-2. This result was statistically highly
significant (p = 6.6 × 10-6). All of these values for Lig 3 and GW 3 match up
fairly closely with the whole embryo results, further supporting the conclusion
that moving the Pax6 upstream enhancers closer to the TSS reduces expression to
about 30 to 40% of the normal value.
The negative control set of embryos from trial set 2 was also analyzed by
the trunk-based method; these results appear in Figure 7 and Figure 9. The raw
score for this negative control set was 290 ± 304. This value comes out to 14% of
Lig 1-2 or 24% of GW 1-2; the measurement shown in Figure 9 is normalized
against Lig 1-2. This result was statistically very significant based on the t-test
result (p = 3.3 × 10-9). For a no-DNA control this value is somewhat high. The
reason for this high value is that the embryos show higher autofluorescence in the
brain than in the rest of the trunk, and the brain is intentionally excluded from the
autofluorescence measurements. This means that the true GFP fluorescence
values are likely to be lower than the measured values for all embryos.
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DISCUSSION
CiPax6 upstream enhancers show sensitivity to changes in their
position and orientation. Based upon the results of this study, changes in either
the position of the UB-UA enhancer cassette or its orientation severely reduce or
eliminate expression of GFP. The effect of altering the orientation of these
enhancers is a substantial loss of expression; two trials using GW 2 gave
normalized fluorescence values of 12% to 53% of the corresponding controls
using the more reliable trunk based measurements. Repositioning the enhancer
cassette 500 to 600 bp upstream of the TSS also severely reduces expression of
GFP, but there is still visible expression in some embryos transformed with Lig 3.
All three trials using either Lig 3 or GW 3 gave normalized values within the
range of 33% to 42% of the appropriate positive control based on both whole
embryo measurements and trunk based measurements.
The inability to avoid autofluorescence during the data analysis was a
limiting factor in this study, particularly in the whole embryo analysis. The ideal
solution to this problem would be to analyze only the sensory vesicle and nerve
cord, thereby avoiding nearly all autofluorescence. However, these regions
generally were not distinguishable unless there was very strong GFP expression.
For this reason analysis of only the nerve cord and sensory vesicle would have
required additional labeling of these regions in experimental and negative control
embryos. This technique was not used in this investigation but could be applied to
future analyses.
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One issue that should be addressed from these results is the observation
that there was a consistent difference in GFP expression between the positive
controls Lig 1 and GW 1. GW 1 gave fluorescence values that were
approximately 70% of Lig 1 fluorescence based on whole embryo measurements
or 65% based on trunk measurements. The only sequence differences between
these two vectors are a single base deletion in Lig 1 and differences at the 5’ and
3’ ends of the enhancer cassette. Differences at the 5’ and 3’ ends include
remnants of the recombination cassette used in the Gateway method, including an
attB1 site at the 5’ end and an attB2 site at the 3’ end; as well as a 12 bp stretch of
DNA found in Lig 1 that is missing from GW 1. The 5’ difference does not affect
the region previously identified as enhancer sequence. In addition, Lig 1 gives the
highest level of expression of all vectors tested, so the single base deletion found
in this vector cannot be responsible for the loss of expression seen in the other
constructs. Therefore the difference at the 3’ end of the enhancer cassette appears
to be the only explanation for the reduction in expression from GW 1. The
locations of the two enhancers were previously determined by a series of PCRbased deletions from the 5’ end of the upstream sequence (Irvine et al., 2008).
The study did not make use of 3’ deletions to determine the TSS-proximal end of
the enhancer cassette; instead this 3’ boundary was identified from the minimum
sequence whose deletion eliminated detectable expression of GFP. This leaves
the possibility that the real 3’ edge of the UA element is actually downstream of
the predicted position, and that this element has consequently been interrupted in
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GW 1 as well as all experimental constructs. The Irvine lab is currently working
on the production of new experimental constructs that retain additional sequence
at the 3’ end of the enhancer cassette. Another possibility, discussed more in the
next section of this discussion, is that the sequences flanking the enhancer cassette
somehow modify the activity of the enhancers (Elion and Warner, 1986). While
this may explain the modest loss of expression in GW 1, there appears to be an
additional and much greater loss of expression when the position or orientation of
the enhancers is also altered.
Other examples of position or orientation sensitivity have been
documented but have often been overlooked. Many studies, including those
referenced in this thesis, have found some loss of enhancer activity when the
position or orientation of an enhancer element is altered. One clear example of
orientation sensitivity already mentioned in the introduction was the study of two
cis-regulatory elements of the Peg3 and Usp29 bidirectional promoter (Kim et al.
2008). The enhancer CSE2 consists of a series of binding sites for the TF YY1;
the CSE1 element is a silencer for both Peg3 and Usp29. Both of these elements
are found within the first intron of Peg3. In this study the expression of a reporter
gene was measured at 1.7 fold when both the CSE1 and CSE2 elements were
present. The expression level was defined as 1.0 fold for a construct containing
the silencer CSE1 but not the enhancer CSE2. Inversion of the entire CSE2
element gave a 1.1-fold level of expression; a similar value was observed when all
YY1 sites were abolished by mutation. This was interpreted by the authors of the
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article as orientation dependence of this element. The CSE1 element was also
found to be orientation sensitive. A construct containing CSE2 but not CSE1 gave
a 2.7-fold level of expression due to the loss of silencer function of CSE1 in the
reverse orientation. Inversion of CSE1 (with no alteration to CSE2) gave an
expression level of 2.5 fold, suggesting that its silencer activity was nearly
completely lost in the reverse orientation. The CSE1 element was also tested in a
different location, 3’ of the Peg3-differentially methylated region (DMR) where
the enhancers are normally found. The expression with CSE1 in this new position
was about 1.4 fold with CSE1 in the forward orientation and 1.8 fold with CSE1
in the reverse orientation, which showed that this silencer was fully functional,
perhaps slightly more functional, in the altered position.
The study by Small et al. (1993) uncovered an example of extreme
position sensitivity of two enhancers in the eve gene in Drosophila, as mentioned
in the introduction. The eve gene controls the proper patterning of segmentation
stripes in the Drosophila embryo. Stripes 2 and 3 are under the control of separate
upstream enhancers; these two enhancers are separated by a 1.7 kb spacer of noncoding DNA. It was discovered that this 1.7 kb fragment could be removed and
replaced with a different spacer without altering the stripe pattern produced. The
spacer fragment used could even be of a different size than the natural 1.7 kb
fragment; one fragment that preserved the stripe patterning was only 160 bp in
size. When the two enhancers were linked, however, abnormal expression
patterns resulted. Similar effects were seen when the positions of the stripe 2
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enhancer and the stripe 3 enhancer were switched with or without a spacer,
although the abnormal pattern seen with the linked enhancers was different
depending on which enhancer was positioned first. This indicated that the normal
stripe pattern was dependent on the separation of the two stripe enhancers by
some spacer. The position sensitivity of these enhancers differs from other
examples of position or orientation sensitivity in that the proper function of these
enhancers is dependent on their distance from each other, not from the TSS.
Nonetheless, this example illustrates the idea that enhancer position can reflect the
need for the proper genomic context.
Many studies of cis-regulatory elements from the 1980s also uncovered
some apparent sensitivity to changes in position or orientation. At this time,
however, the definition of cis-regulatory elements as flexible in their position and
orientation was newly established as a criterion for defining such an element as an
enhancer. To satisfy this criterion, it was enough for a newly discovered enhancer
to show that the enhancer in the altered setup still increased expression of the
target gene to a significant extent. Many cases of substantial reduction in
enhancer activity in these altered constructs were therefore ignored at the time.
For example, the study by Jaynes et al. (1988) found that a muscle-specific
enhancer located 1050 bp upstream of the muscle creatine kinase gene retained
100% of its enhancer activity when moved to a position 80bp upstream of the
TSS, but expression dropped to around 20% when the enhancer was either moved
downstream of the reporter gene chloramphenicol acetyltransferase (CAT) in
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either orientation, or inverted in orientation at the -80 position. It should be noted
that the constructs that gave this strong decrease in expression had deletions of all
upstream sequence excluding the enhancer element to position -80. A set of
constructs with the enhancers in the downstream position (in either orientation)
and with upstream deletions only to position -776 gave between 42 and 74%
expression. The study by Shaul et al. (1985) found that an enhancer for the
hepatitis B virus core antigen (HBcAg) promoter gave levels of CAT activity
ranging from 50 to 300 in the forward orientation, but the enhancer in the reverse
orientation gave CAT activity ranging from 25 to 50. These numbers are
normalized to a comparable construct using an enhancer from simian virus 40
(SV40), which was defined as an activity level of 100. Similarly, Laimins et al.
(1984) found that an enhancer from the long terminal repeat of Moloney murine
sarcoma virus gave nearly equal CAT expression in the forward and reverse
orientations but was only 30 to 40% active when moved downstream of the CAT
gene in either orientation.
Elion and Warner (1986) discovered an example of position and
orientation sensitivity in a yeast ribosomal DNA (rDNA) enhancer. The position
sensitivity was slight; expression was just under 60% of the default position
expression when the upstream enhancer was moved closer to the TSS or
downstream of the target gene. The result of inversion of the enhancer was
initially found to be a complete loss of enhancer function. However, this effect
was further examined in the study by inverting a larger fragment consisting of the
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correctly oriented enhancer flanked by about 750 bp of non-enhancer DNA on
either side. The resulting vector restored enhancer activity to about 50% in spite
of the inverted enhancer orientation in this construct. When this same larger
inversion was performed on the test vector with the minimal enhancer already
inverted, the resulting vector showed virtually no enhancer activity even though
the enhancer ended up in the forward orientation. It was concluded that the
observed loss of enhancer activity was due to a silencing effect of the fusion of
the 3’ end of the inverted enhancer with pBR322 vector sequence normally found
at the 5’ end of the enhancer.
Taken together, these examples demonstrate that many enhancers show
some sensitivity to changes in position and orientation. The degree of sensitivity
varies from one enhancer to the next and may also depend on the nature of the
change. Some enhancers are sensitive to changes in position but not in orientation,
or vice versa; some enhancers also appear to show different degrees of activity
when different combinations of position and orientation changes are introduced
(Kim et al., 2008; Elion and Warner, 1986). In some cases (Small et al., 1993;
Jaynes et al., 1988; Elion and Warner, 1986) the activity of an enhancer was
found to be influenced by other nearby sequence elements, which may point to a
universal explanation of why certain enhancers are only fully functional in the
naturally occurring position or orientation.
Aside from a misidentification of the minimal enhancer sequence, there
are several possible ways that an enhancer could be dependent on other sequence
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elements. Two such possibilities are discussed in the following paragraphs. One
simple explanation is that there may be other TF binding sites outside of the
defined minimal enhancer, and TFs bound to these external sites interact with
enhancer-bound TFs to bring about 100% transcriptional activation. These
external sites could be deleted or interrupted in some of the altered constructs,
preventing the TFs from binding these sites. Conversely, if there are multiple TF
binding DNA elements that must interact with the basal promoter through bound
TFs, inverting or repositioning one such element, such as the enhancer, may alter
the formation of the necessary loop structure and thereby prevent transcription.
An alternate explanation for sensitivity to genomic context is that
sequences flanking an enhancer may play a critical role in TF binding. In higher
organisms, DNA exists as part of the material chromatin, a complex of the DNA
and various bound proteins referred to as histones. Most of the DNA in chromatin
is found in nucleosomes, which are composed of stretches of approximately 147
bp of DNA wrapped around a core of eight histones (Segal and Widom, 2009).
Certain DNA sequences are favorable for nucleosome formation, while other sites
tend to remain nucleosome-free or have lower nucleosome density because the
sequence is less favorable for nucleosome occupancy (reviewed in Segal and
Widom, 2009). TFs cannot bind their target sites when nucleosomes occur at
these sites, meaning that TF binding sites must either occur in nucleosome-free
stretches of DNA or be subject to some mechanism of nucleosome displacement.
Some DNA sequences that are unfavorable for nucleosome formation tend to
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prevent nucleosomes from developing in flanking sequences as well, which
means that enhancers located adjacent to nucleosome-free regions may be more
accessible to their TFs (Segal and Widom, 2009). Altering the position or
orientation of such an enhancer could therefore reduce TF binding. This effect
will often be visible using transient plasmids, in which the DNA appears to form
nucleosomes in a normal fashion, although higher order chromatin structures may
differ from those seen in the correct genomic context (Hebbar and Archer, 2008).
Changes in enhancer position or orientation may affect processes
other than target gene expression. There have been a few studies that have
linked changes in enhancer position or orientation to deficiencies in processes not
related to gene expression. One such study was performed by Bachl et al. (1998).
The focus of this study was the intronic enhancer for the heavy (H) chain of the
immunoglobulin (Ig) gene, specifically the role of this enhancer in hypermutation
in the variable (V) region of the H chain. For this study the Ig basal promoter was
replaced with a thymidine kinase (tk) promoter fused to the SV40 enhancer; this
chimeric promoter had previously been found to work in hypermutation
experiments. The rest of the Ig gene was left intact. Deletion of the intronic
enhancer caused a roughly 100-fold decrease in the mutation rate, showing that
this enhancer is necessary for the natural hypervariability of the V region.
Similarly, a construct with the intronic enhancer in the reverse orientation showed
a 10-fold drop in the mutation rate, and there was a 7-fold drop in mutation
frequency when the enhancer was repositioned 3’ of the entire V region. These
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decreases in hypermutation were not accompanied by changes in H chain
expression, since the levels of mRNA produced from these different constructs
appeared to be close to equal on a gel.
Another study by Chandrasekharappa and Subramanian (1987) focused
on the connection between the 72-bp-repeat enhancer in SV40 and the process of
DNA replication. One significant finding of this study was that DNA replication
at the SV40 core replication origin was dependent upon the distance between this
core origin and the 72-bp-repeat enhancer. The core origin and enhancer are
separated by less than 100 bp in SV40. Compared to a vector with the SV40 core
origin but without the enhancer, vectors containing both elements separated by 8
or 9 bp gave an approximately tenfold increase in replication efficiency, while
those containing the two elements separated by 99 bp or more gave a replication
efficiency equal to or lower than the enhancer-less vector. The increase in DNA
replication was not sensitive to changes in the enhancer orientation; however, it
was found that activation of DNA replication occurred only when the end of the
core origin containing the 17 bp A+T rich element was facing the enhancer. This
was true regardless of whether the core origin was found in its default position or
moved to the opposite end of the enhancer. This study also noted that the 72-bprepeat enhancer is not position or orientation sensitive as a transcriptional
activator.
Conservation of enhancer position and orientation is not a definitive
indicator of sensitivity of that enhancer to position or orientation changes.
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Genetic sequence conservation is a useful tool for locating genes as well as
functional non-coding DNA elements, since preservation of sequence between
distantly related species tends to represent selective pressure against any mutation
in that element. Similarly, one may infer that if the position or orientation of a cisregulatory element is evolutionarily conserved, then the observed position or
orientation of that element is critical for its function. This appears to be the case
for the C. intestinalis Pax6 upstream enhancers, which show position and
orientation conservation with Pax6 in C. savignyi (Irvine et al., 2008) and were
found in this study to be sensitive to changes in both position and orientation.
While C. intestinalis and C. savignyi are rather closely related species for such a
determination of sequence conservation, Pax6 homologs such as mouse Pax6 and
the Drosophila gene eyeless have slightly different sets of enhancers (reviewed in
Irvine et al., 2008), making such a determination of position or orientation
conservation impossible for these larger evolutionary distances. Other examples
of enhancers with conserved position and orientation have shown more flexibility
than Pax6. The study by Kim et al. (2008) noted that the position and orientation
of the CSE1 element were evolutionarily conserved relative to the TSS in
mammals. The orientation of the entire CSE2 element, and the orientation of all
individual YY1 binding sites within this element, were also conserved. The
functional analysis found that both elements were orientation sensitive, but the
CSE1 element was clearly flexible in its position relative to the TSS. In the
Drosophila eve gene, the promoter arrangement is conserved between D.
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melanogaster and the rather distant relative D. grimshawi (Small et al., 1993).
This conservation includes the position of the stripe 3 enhancer upstream of the
stripe 2 enhancer; yet the positions of these two enhancers can be switched
without a visible effect on the stripe pattern that develops.
Examples such as these do support the logical hypothesis that enhancers
that are sensitive to changes in position or orientation will show the corresponding
evolutionary conservation, but not all examples of conservation point to
inflexibility in the genomic environment. The inconsistency of this relationship
between position or orientation conservation and position or orientation
sensitivity creates more questions than answers. One possibility is that some of
these conserved enhancers have other roles outside of transcriptional activation,
and that there is some type of sensitivity to genomic context in this alternate role.
The conserved position or orientation in these cases would be a reflection of the
non-transcriptional function of the enhancer. This explanation is likely to apply to
a few specific cases but is not likely to provide a general reconciliation of
contextual conservation with position or orientation flexibility. Another
possibility is that the flexibility seen using transgenic plasmids does not reflect the
true genomic context of these enhancers. This could be due to differences in
chromatin structure in the plasmid versus the genome (Hebbar and Archer, 2008),
or it could be due to interaction of TFs that bind the enhancer with TFs bound to a
different sequence element that was not included in the experimental plasmids.
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The results of this study and others create new questions about the
nature of enhancers and other cis-regulatory DNA modules. One of the
defining criteria of an enhancer is that it is capable of increasing expression of its
target gene in a position- and orientation-independent manner. This idea continues
to be well supported even by the findings of this study, although there may be
exceptions to this definition (Kim et al., 2008). However, this definition does not
mandate that enhancers in an altered position or orientation function as effectively
as in their default setup. This study, along with other studies discussed earlier,
indicate that many enhancers lose much of their activity when they are
repositioned or inverted. This raises the questions of how widespread this trend is
among enhancers and whether there is a pattern to which enhancers show such
sensitivity.
Investigation of these new questions could begin with genomic screening
for identified enhancer elements that show conservation in their position and
orientation across species. Elements that show such conservation relative to their
target genes are most likely to be sensitive to inversion or repositioning.
Functional studies could then be employed to identify which of these enhancers
are position or orientation sensitive. Once these enhancers have been identified,
the next step would be to look for patterns that may explain why these enhancers
are sensitive to position or orientation changes while others are not. It may be that
enhancers for certain types of genes are less tolerant of changes in position or
orientation, or sensitivity to position or orientation may reflect a dependence on
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genomic context that is common to all of these enhancers. This type of position or
orientation sensitivity could also have a substantial biomedical impact in cases
where proper gene function is sensitive to the level of expression. In these cases
inversion or repositioning of an enhancer could affect expression levels enough to
alter the phenotype of an organism or, in the case of Pax6 or other developmental
regulators, produce a developmental disorder. This may also explain the observed
phenomenon of evolutionary constraint of position and orientation in certain
enhancers. The results of these future studies will build upon our current
understanding of how enhancers function.
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